- Home
- / CytImmune
CytImmune
CytImmune Summary
Company Summary
- Overview
- CytImmune Sciences is a company that specializes in the field of cancer nanomedicine. It uses its Aurimune platform to develop CYT-6091, a colloidal gold-based tumor-targeted nanomedicine.
- Type
- Private
- Status
- Active
- Founded
- 1996
- Website
- https://cytimmune.blog
- Cybersecurity rating
Table of Contents
Key People
David Oarr, President
Gary Rosenfeld, Chief Financial Officer
Mitchell S. Marder, Corporate Development and Chief Legal Officer
Footer menu
Product
- Intelligence Suite
- Supplier Intelligence Platform
- Craft Intelligence Portal
- Craft API
- Craft for Teams
- Supplier Intelligence Platform
- Craft Alerts
- Craft N-Tier Mapping
- Craft Risk Hub
- Chrome extension
Resources
© Craft.co 2026